132 related articles for article (PubMed ID: 31558923)
21. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems.
Pirog EC; Erroll M; Harigopal M; Centeno BA
Arch Pathol Lab Med; 2004 May; 128(5):527-32. PubMed ID: 15086283
[TBL] [Abstract][Full Text] [Related]
22. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
23. Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women.
Donders GG; Depuydt CE; Bogers JP; Vereecken AJ
PLoS One; 2013; 8(12):e86266. PubMed ID: 24386492
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
[TBL] [Abstract][Full Text] [Related]
25. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.
Firnhaber C; Van Le H; Pettifor A; Schulze D; Michelow P; Sanne IM; Lewis DA; Williamson AL; Allan B; Williams S; Rinas A; Levin S; Smith JS
Cancer Causes Control; 2010 Mar; 21(3):433-43. PubMed ID: 19949850
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
27. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
29. Atypical glandular cells in Papanicolaou test: Which is more important in the detection of malignancy, architectural or nuclear features?
Yucel Polat A; Tepeoglu M; Tunca MZ; Ayva ES; Ozen O
Cytopathology; 2021 May; 32(3):344-352. PubMed ID: 33606313
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women.
Schnatz PF; Markelova NV; Holmes D; Mandavilli SR; O'Sullivan DM
J Womens Health (Larchmt); 2008 Mar; 17(2):279-85. PubMed ID: 18321179
[TBL] [Abstract][Full Text] [Related]
32. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
33. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
34. Cytohistological discrepancies of cervico-vaginal smears and HPV status.
Alanbay İ; Öztürk M; Fıratlıgil FB; Karaşahin KE; Yenen MC; Bodur S
Ginekol Pol; 2017; 88(5):235-238. PubMed ID: 28580567
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
[TBL] [Abstract][Full Text] [Related]
36. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
37. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
Shlay JC; McGill WL; Masloboeva HA; Douglas JM
Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Fokom Domgue J; Cunningham SA; Yu RK; Shete S
Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
[TBL] [Abstract][Full Text] [Related]
39. Cost--effectiveness of pap smear in Kermanshah, Iran.
Nokiani FA; Akbari H; Rezaei M; Madani H; Ale Agha ME
Asian Pac J Cancer Prev; 2008; 9(1):107-10. PubMed ID: 18439087
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of high risk human papillomavirus (HPV) infection and abnormal cervical cytology and knowledge about HPV vaccine in Eastern Turkey.
Sahin HG; Kolusari A; Guducuoglu H
Eur J Gynaecol Oncol; 2017; 38(2):241-244. PubMed ID: 29953788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]